Plasmapheresis Market: Integration of Innovative Features & Technological Advanc

Posted by Arslan on April 19th, 2019

 A treatment method which developed over a period of two decades and involves the removal and replacement of patient’s circulating plasma is aimed to remove disease-linked molecules and hence interrupt disease progression. Plasmapherisis has been applied in the treatment of lupus nephritis in order to eliminate circulating immune complexes and pathogenic antibodies. Accordingly, patients with overwhelming disease in whom standard therapy does not work may use plasmapheresis treatment. As such, the case of thrombotic thrombocytopenic purpura (TTP) has surged in those with SLE. Thus, priority on upgrading healthcare infrastructure coupled with growing awareness on treating TTP and autoimmune diseases has been witnessed.

Over the last decade or so, biologic agents have used intensively to treat cancer and autoimmune conditions. There has been rising incidence of autoimmune diseases such as type 1 diabetes, lupus, rheumatoid arthritis and psoriasis. Rampant autoimmune diseases continues to drive the demand for extracorporeal therapies. Embracement of plasmapheresis eradicates putative pathogenic autoantibodies and thereby, circulates the immune complexes from patients’ blood with systematic lupus erythematosus.

Addressing the above issue, manufacturers in the healthcare industry are relentlessly integrating innovative features and technological advancements in the plasmapheresis instruments such as aspheresis machines.

On account of escalating need for plasma for the treatment of cancer, burns, heart diseases, anemia the demand for the donation of the blood products has spurred. Additionally, the use of blood products is highly sought after for the production of biopharmaceutical medications—for the treatment of diabetes, arthritis and cancer.

Biopharmaceutical Companies to Represent a Leading Segment

Growing need to conduct plasmapheresis has led to surge in demand for various instruments in the global market. On the basis of product type, the instruments segment is expected to represent the highest revenue growth, accounting for a value of over US$ 260 Mn by the end of 2026. However, the disposables product segment is expected to register a robust CAGR during the forecast period.

According to U.S. National Library of Medicine, the prevalence rate of TTP is in the range of 1.7 to 11 cases per million population in the U.S. In addition to TTP, increase in prevalence of autoimmune diseases and advancement in plasmapheresis is likely to drive the growth of the market during the assessment period in the U.S. The market in Europe is likely to mimic the U.S. in terms of key driving factors, whereas greater emphasis on boosting healthcare infrastructure is likely to fuel market growth in Asia Pacific excluding Japan (APEJ) and Latin America. In terms of revenues, North America will continue to be a leading market, with U.S. accounting for the bulk of revenues. The U.S. is home to some of the leading companies in the plasmapheresis market, and there is a high emphasis on research and development among universities and institutes. Collaboration between companies and institutions has also contributed to the growth of the market in the region.

Plasmapheresis Market: Overview

The report offers a coherent analysis on the plasmapheresis market for the forecast period 2018-2026. Further, the report also shed light on dynamics of the market, including drivers, trends, restraints and opportunities. Besides, the report delves into the segmentation of the market which is aimed at providing readers with an in-depth view of the market.

Browse Full Report with ToC Here: 

https://www.factmr.com/report/351/plasmapheresis-market

The report on plasmapheresis delves into supply chain and cost structure to provide a robust view of the plasmapheresis market. The report also includes product lifecycle analysis. Furthermore, PESTLE analysis offers an in-depth view of plasmapheresis in the global market. The report also includes a comprehensive assessment on the basis of average pricing analysis. The report also delves into the list of distributors and patents along with the approvals. The report also includes the strategic framework adopted by players in the market.

The market for plasmapheresis adopts supply-demand approach to provide a holistic picture of the market. In-house panel of experts have thoroughly analyzed the research sources, including secondary sources and primary sources. Revenue comparison, market share comparison and Y-o-Y growth comparison on the geography lead to the market size of the plasmapheresis. The growth of manufacturers in the historical and forecast period are estimated to assist the readers with investment decisions.

Plasmapheresis Market: Competitive Landscape

Leading players being instrumental for the growth of the plasmapheresis market are assessed and profiled with respect to financial overview, company overview, product offering, strategies, recent development and key differentiators. Furthermore, the report encompasses SWOT analysis to present an overall picture of the competitive landscape of the plasmapheresis market. The market presence is on the basis of intensity map on the basis of region.

Leading market players operating in the global plasmapheresis market include Haemonetics Corporation, Asahi Kasei Kuraray Medical, Terumo Corporation, B Braun Melsungen AG, Baxter Internationalaq IncR4T554RFDD., Fresenius SE & Co. KGaA, Kawasumi Laboratories, Inc. and Kaneka Corporation.